Oncology is a good example of this trend, with recent developments by early-stage businesses in the areas of immunotherapy, CAR-T cells, e-health and artificial intelligence. The Covid health crisis demonstrated that many biotechnology companies spun off from academic research have the ability to offer disruptive innovations (vaccines, tests, etc.). LS LEAD training center (Life Science Leadership School).The MATWIN innovation accelerator (the consortium’s coordinator).The Gustave Roussy Comprehensive Cancer Center.The Carnot Institutes specifically targeting cancer: Curie Cancer (linked to Institut Curie), CALYM for lymphomas and OPALE for leukemia and related diseases.Cancer research clusters (Canceropoles): CLARA (Lyon Auvergne-Rhône-Alpes), Sud (Provence Alpes Côte d’Azur), Grand-Ouest (Brittany, Centre, Pays de la Loire) and Nord-Ouest (Normandy, Hauts de France).
The OncoSTART steering committee currently has 12 members: This new group aims to drive the creation of high added-value start-ups in the oncology sector and support the development of a network with a more visible international presence to better cater to patients’ needs.
#Viavoice french download#
More information (Fr) To download documents, you can right-click on the links above and chose "Save link as."īordeaux, France, Created at the initiative of MATWIN, the French accelerator dedicated to oncology innovation, the OncoSTART consortium brings together 12 key national players in research and innovation in the fight against cancer, pooling their specific expertise, know-how and networks. A French open-innovation platform dedicated to promoting innovation in oncology